首页 > 最新文献

Human Antibodies最新文献

英文 中文
Singleton pregnancy losses before gestational week 22 among patients with autoimmune disorders and methylenetetrahydrofolate reductase polymorphisms. 自身免疫性疾病和亚甲基四氢叶酸还原酶多态性患者在妊娠22周前的单胎妊娠丢失
Q3 Medicine Pub Date : 2022-01-01 DOI: 10.3233/HAB-211517
Murat Cagan, Ummuhan Okuducu, Hanife Guler Donmez, Mehmet Sinan Beksac

Background: The rates of pregnancy losses (PLs) are increased by maternal risk factors such as autoimmune disorders (AD) and methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms.

Objective: To evaluate singleton PLs before gestational week (gw) 22 among patients with AD and MTHFR polymorphisms.

Methods: Totally, 1108 singleton pregnancies in 243 women were categorized as: 1) 148 pregnancies in 33 patients with AD, 2) 316 pregnancies in 66 patients with MTHFR polymorphisms, 3) 644 pregnancies in 144 patients with AD +MTHFR polymorphisms. PLs were classified into subgroups: a) Chemical Pregnancy(CP), b) Blighted Ovum(BO), c) gw ⩽ 10, d) gw11-14 e) gw15-22, f) Ectopic Pregnancy(EP), g) Trophoblastic Disease(TD). Obstetric histories were compared using Beksac Obstetrics Index (BOI): [number of living child + (π/10)]/gravida.

Results: PL rates before gw22 were 39.2% (58/148), 33.2% (105/316), and 36.3% (234/644) in AD, MTHFR, and AD +MTHFR groups, respectively (p= 0.421). The rate of Pre-Prenatal Screening Period fetal losses (CP + BO + gw ⩽ 10 fetal losses + EP + TD) were 84.8%, 75.9%, and 77.8% in AD, MTHFR, and AD +MTHFR, respectively (p= 0.264). Gravidity ⩽ 4 versus those with gravidity ⩾ 5 had statistically significant differences in BOI (p< 0.001).

Conclusions: PL rate before gw22 among singleton pregnancies with AD and/or MTHFR polymorphisms was 35.8%. The clinical findings seem to be more complicated in patients with gravidity ⩾ 5.

背景:母体自身免疫性疾病(AD)和亚甲基四氢叶酸还原酶(MTHFR)基因多态性等危险因素增加了妊娠损失(PLs)的发生率。目的:评价AD和MTHFR多态性患者妊娠周前单胎PLs (gw) 22。方法:243例1108例单胎妊娠分为:AD患者33例148例妊娠,MTHFR多态性66例316例妊娠,AD +MTHFR多态性144例644例妊娠。PLs分类为:a)化学妊娠(CP), b)卵衰症(BO), c) gw≤10,d) gw11-14, e) gw15-22, f)异位妊娠(EP), g)滋养层疾病(TD)。产科史比较采用Beksac产科指数(BOI):[活胎数+ (π/10)]/妊娠。结果:AD组、MTHFR组、AD +MTHFR组gw22前的PL率分别为39.2%(58/148)、33.2%(105/316)、36.3%(234/644),差异有统计学意义(p= 0.421)。AD、MTHFR和AD +MTHFR产前筛查期胎儿损失率(CP + BO + gw≥10胎损+ EP + TD)分别为84.8%、75.9%和77.8% (p= 0.264)。重力≥4与重力小于5的人在BOI上有统计学上显著差异(p< 0.001)。结论:AD和/或MTHFR多态性的单胎妊娠gw22前的PL率为35.8%。在妊娠大于或等于5的患者中,临床发现似乎更复杂。
{"title":"Singleton pregnancy losses before gestational week 22 among patients with autoimmune disorders and methylenetetrahydrofolate reductase polymorphisms.","authors":"Murat Cagan,&nbsp;Ummuhan Okuducu,&nbsp;Hanife Guler Donmez,&nbsp;Mehmet Sinan Beksac","doi":"10.3233/HAB-211517","DOIUrl":"https://doi.org/10.3233/HAB-211517","url":null,"abstract":"<p><strong>Background: </strong>The rates of pregnancy losses (PLs) are increased by maternal risk factors such as autoimmune disorders (AD) and methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms.</p><p><strong>Objective: </strong>To evaluate singleton PLs before gestational week (gw) 22 among patients with AD and MTHFR polymorphisms.</p><p><strong>Methods: </strong>Totally, 1108 singleton pregnancies in 243 women were categorized as: 1) 148 pregnancies in 33 patients with AD, 2) 316 pregnancies in 66 patients with MTHFR polymorphisms, 3) 644 pregnancies in 144 patients with AD +MTHFR polymorphisms. PLs were classified into subgroups: a) Chemical Pregnancy(CP), b) Blighted Ovum(BO), c) gw ⩽ 10, d) gw11-14 e) gw15-22, f) Ectopic Pregnancy(EP), g) Trophoblastic Disease(TD). Obstetric histories were compared using Beksac Obstetrics Index (BOI): [number of living child + (π/10)]/gravida.</p><p><strong>Results: </strong>PL rates before gw22 were 39.2% (58/148), 33.2% (105/316), and 36.3% (234/644) in AD, MTHFR, and AD +MTHFR groups, respectively (p= 0.421). The rate of Pre-Prenatal Screening Period fetal losses (CP + BO + gw ⩽ 10 fetal losses + EP + TD) were 84.8%, 75.9%, and 77.8% in AD, MTHFR, and AD +MTHFR, respectively (p= 0.264). Gravidity ⩽ 4 versus those with gravidity ⩾ 5 had statistically significant differences in BOI (p< 0.001).</p><p><strong>Conclusions: </strong>PL rate before gw22 among singleton pregnancies with AD and/or MTHFR polymorphisms was 35.8%. The clinical findings seem to be more complicated in patients with gravidity ⩾ 5.</p>","PeriodicalId":53564,"journal":{"name":"Human Antibodies","volume":"30 2","pages":"59-65"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39799966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Immunogenicity of biologics used in the treatment of moderate to severe psoriasis. 用于治疗中重度牛皮癣的生物制剂的免疫原性。
Q3 Medicine Pub Date : 2021-01-01 DOI: 10.3233/HAB-210447
Visha Patel, Alex Efimov, David Baker, Angray S Kang

The number of biologic drugs available for the treatment of psoriasis continue to expand. However, being biological proteins and thus potentially immunogenic, there is evidence that anti-drug-antibodies develop against the various therapeutic proteins currently being utilised. Although chimeric antibodies that contain elements of the parental rodent monoclonal antibodies are immunogenic, anti-drug antibodies occur even if the biologic is a fully human protein and these can impact on clinical efficacy and safety. However, there is a wide variation in the reported level of anti-drug-antibodies for the same and different treatments that is highlighting issues with various assays used in anti-drug antibody detection. Here we review the available data on the occurrence of anti-drug antibodies in people with psoriasis treated with biologic agents.

可用于治疗牛皮癣的生物药物的数量继续扩大。然而,作为生物蛋白,因此具有潜在的免疫原性,有证据表明,针对目前使用的各种治疗蛋白,抗药物抗体会产生。虽然嵌合抗体包含亲代啮齿动物单克隆抗体的元素具有免疫原性,但即使生物制品是完全的人类蛋白质,也会产生抗药物抗体,这些抗体会影响临床疗效和安全性。然而,对于相同和不同的治疗方法,报告的抗药物抗体水平存在很大差异,这突出了用于抗药物抗体检测的各种分析方法的问题。在这里,我们回顾了现有的数据发生抗药物抗体银屑病人与生物制剂治疗。
{"title":"Immunogenicity of biologics used in the treatment of moderate to severe psoriasis.","authors":"Visha Patel,&nbsp;Alex Efimov,&nbsp;David Baker,&nbsp;Angray S Kang","doi":"10.3233/HAB-210447","DOIUrl":"https://doi.org/10.3233/HAB-210447","url":null,"abstract":"<p><p>The number of biologic drugs available for the treatment of psoriasis continue to expand. However, being biological proteins and thus potentially immunogenic, there is evidence that anti-drug-antibodies develop against the various therapeutic proteins currently being utilised. Although chimeric antibodies that contain elements of the parental rodent monoclonal antibodies are immunogenic, anti-drug antibodies occur even if the biologic is a fully human protein and these can impact on clinical efficacy and safety. However, there is a wide variation in the reported level of anti-drug-antibodies for the same and different treatments that is highlighting issues with various assays used in anti-drug antibody detection. Here we review the available data on the occurrence of anti-drug antibodies in people with psoriasis treated with biologic agents.</p>","PeriodicalId":53564,"journal":{"name":"Human Antibodies","volume":"29 3","pages":"171-178"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3233/HAB-210447","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39251785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Association of increased C-Reactive Protein and hypocomplementemia with risk factors for thrombosis in women who have susceptibility for poor gestational outcome; importance of preconceptional counseling. c -反应蛋白升高和低补体血症与妊娠结局不良易感性妇女血栓形成危险因素的关系先入为主的咨询的重要性。
Q3 Medicine Pub Date : 2021-01-01 DOI: 10.3233/HAB-210452
Mehmet Sinan Beksac, Hanife Guler Donmez
This study aimed to investigate the association of increased C-Reactive Protein (CRP) and hypocomplementemia with risk factors for thrombosis such as Factor V Leiden (FVLP) and Prothrombin G20210A polymorphisms (PP), increased Activated Protein C Resistance (APCR) and decreased anti-thrombin III (ATIII) activity in women who have metabolic (MTHFR polymorphisms) and immunological risk factors (autoimmune antibody positivity, autoimmune disorders, and chronic inflammatory diseases). All patients (n= 197) were evaluated in terms of risk factors for thrombosis including FVLP, PP, increased APCR, and decreased ATIII activity as well as CRP and complement (C) 3 and C4 levels within a framework of preconceptional care program. Patients with high CRP levels together with hypocomplementemia were included to the study group (n= 13), while women with normal levels of CRP, C3, and C4 were accepted as controls (n= 184). Decreased ATIII activity was found to be statistically more frequent in the study group compared to controls (p= 0.036). There were no significant differences between the study and control groups in terms of the presence of FVLP, PP and increased APCR (p= 0.386, p= 0.462, p= 0.625, respectively). Decreased ATIII activity should be the concern of preconceptional and antenatal care programs in risky patients with increased CRP levels and hypocomplementemia in order to prevent placental inflammation related gestational complications.
本研究旨在探讨在具有代谢(MTHFR多态性)和免疫危险因素(自身免疫抗体阳性、自身免疫性疾病和慢性炎症性疾病)的女性中,C反应蛋白(CRP)升高和低补体血症与血栓形成危险因素(如V - Leiden因子(FVLP)和凝血酶原G20210A多态性(PP)、活化蛋白C抵抗(APCR)升高和抗凝血酶III (ATIII)活性降低的关系。所有患者(n= 197)在孕前护理计划框架内评估血栓形成的危险因素,包括FVLP, PP, APCR升高,ATIII活性降低以及CRP和补体(C) 3和C4水平。高CRP水平合并低补体血症的患者被纳入研究组(n= 13),而CRP、C3和C4水平正常的女性被接受为对照组(n= 184)。研究发现,与对照组相比,研究组的ATIII活性降低在统计学上更为频繁(p= 0.036)。在FVLP、PP的存在和APCR的升高方面,研究组与对照组无显著差异(p= 0.386、p= 0.462、p= 0.625)。对于CRP水平升高和补体不足的高危患者,应注意孕前和产前护理,以预防胎盘炎症相关的妊娠并发症。
{"title":"Association of increased C-Reactive Protein and hypocomplementemia with risk factors for thrombosis in women who have susceptibility for poor gestational outcome; importance of preconceptional counseling.","authors":"Mehmet Sinan Beksac,&nbsp;Hanife Guler Donmez","doi":"10.3233/HAB-210452","DOIUrl":"https://doi.org/10.3233/HAB-210452","url":null,"abstract":"This study aimed to investigate the association of increased C-Reactive Protein (CRP) and hypocomplementemia with risk factors for thrombosis such as Factor V Leiden (FVLP) and Prothrombin G20210A polymorphisms (PP), increased Activated Protein C Resistance (APCR) and decreased anti-thrombin III (ATIII) activity in women who have metabolic (MTHFR polymorphisms) and immunological risk factors (autoimmune antibody positivity, autoimmune disorders, and chronic inflammatory diseases). All patients (n= 197) were evaluated in terms of risk factors for thrombosis including FVLP, PP, increased APCR, and decreased ATIII activity as well as CRP and complement (C) 3 and C4 levels within a framework of preconceptional care program. Patients with high CRP levels together with hypocomplementemia were included to the study group (n= 13), while women with normal levels of CRP, C3, and C4 were accepted as controls (n= 184). Decreased ATIII activity was found to be statistically more frequent in the study group compared to controls (p= 0.036). There were no significant differences between the study and control groups in terms of the presence of FVLP, PP and increased APCR (p= 0.386, p= 0.462, p= 0.625, respectively). Decreased ATIII activity should be the concern of preconceptional and antenatal care programs in risky patients with increased CRP levels and hypocomplementemia in order to prevent placental inflammation related gestational complications.","PeriodicalId":53564,"journal":{"name":"Human Antibodies","volume":"29 4","pages":"249-254"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3233/HAB-210452","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39194924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic value of procalcitonin, erythrocyte sedimentation rate (ESR), quantitative C-reactive protein (CRP) and clinical findings associated with osteomyelitis in patients with diabetic foot. 降钙素原、红细胞沉降率(ESR)、定量c反应蛋白(CRP)及临床表现与糖尿病足骨髓炎的诊断价值
Q3 Medicine Pub Date : 2021-01-01 DOI: 10.3233/HAB-210439
Zahra Soleimani, Fatemeh Amighi, Zarichehr Vakili, Mansooreh Momen-Heravi, Seyyed Alireza Moravveji

Background: The diagnosis of osteomyelitis is a key step of diabetic foot management. Procalcitonin (PCT) is a novel infection marker. This study aimed to investigate the diagnostic value of procalcitonin and other conventional infection markers and clinical findings in diagnosis of osteomyelitis in diabetic foot patients.

Methods and materials: This diagnostic value study was carried out on ninety patients with diabetic infected foot ulcers admitted in Kashan Beheshti Hospital, 2016. After obtaining consent, 10 cc blood sample was taken for measuring serum PCT, CBC, ESR, CRP and FBS. Clinical characteristics of the wounds were noted. Magnetic resonance imaging of the foot was performed in all patients to diagnose osteomyelitis. All statistical analyses were done with the use of SPSS-16.

Results: PCT levels were 0.13 ± 0.02 ng/mili patients with osteomyelitis (n= 45) and 0.04 ± 0.02 ng/ml in patients without osteomyelitis (n= 45). PCT, Erythrocyte sedimentation rate and C-reactive protein was found significantly higher in patients with osteomyelitis (p< 0.001). The ROC curve was calculated for PCT. The area under the ROC curve for infection identification was 1 (p< 0.001). The best cut-off value for PCT was 0.085 ng/ml. Sensitivity, specificity, and positive and negative predictive values were 100%, 97.8%,97.8% and 100%, respectively.

Conclusion: In this group of patients, PCT was useful to discriminate patients with bone infection. Also, Erythrocyte sedimentation rate and C-reactive protein can be used as a marker of osteomyelitis in diabetic patients.

背景:骨髓炎的诊断是糖尿病足治疗的关键一步。降钙素原(PCT)是一种新型的感染标志物。本研究旨在探讨降钙素原等常规感染标志物及临床表现对糖尿病足骨髓炎的诊断价值。方法与材料:对2016年在Kashan Beheshti医院住院的90例糖尿病感染性足溃疡患者进行诊断价值研究。征得同意后,取血10cc测定血清PCT、CBC、ESR、CRP和FBS。记录伤口的临床特征。所有患者均行足部磁共振成像诊断骨髓炎。所有统计分析均使用SPSS-16进行。结果:骨髓炎患者(n= 45) PCT水平为0.13±0.02 ng/ml,非骨髓炎患者(n= 45) PCT水平为0.04±0.02 ng/ml。骨髓炎患者的PCT、红细胞沉降率和c反应蛋白明显升高(p< 0.001)。计算PCT的ROC曲线,感染鉴定的ROC曲线下面积为1 (p< 0.001)。PCT的最佳临界值为0.085 ng/ml。敏感性为100%,特异性为97.8%,阳性预测值为97.8%,阴性预测值为100%。结论:在本组患者中,PCT可用于鉴别骨感染。红细胞沉降率和c反应蛋白也可作为糖尿病患者骨髓炎的标志物。
{"title":"Diagnostic value of procalcitonin, erythrocyte sedimentation rate (ESR), quantitative C-reactive protein (CRP) and clinical findings associated with osteomyelitis in patients with diabetic foot.","authors":"Zahra Soleimani,&nbsp;Fatemeh Amighi,&nbsp;Zarichehr Vakili,&nbsp;Mansooreh Momen-Heravi,&nbsp;Seyyed Alireza Moravveji","doi":"10.3233/HAB-210439","DOIUrl":"https://doi.org/10.3233/HAB-210439","url":null,"abstract":"<p><strong>Background: </strong>The diagnosis of osteomyelitis is a key step of diabetic foot management. Procalcitonin (PCT) is a novel infection marker. This study aimed to investigate the diagnostic value of procalcitonin and other conventional infection markers and clinical findings in diagnosis of osteomyelitis in diabetic foot patients.</p><p><strong>Methods and materials: </strong>This diagnostic value study was carried out on ninety patients with diabetic infected foot ulcers admitted in Kashan Beheshti Hospital, 2016. After obtaining consent, 10 cc blood sample was taken for measuring serum PCT, CBC, ESR, CRP and FBS. Clinical characteristics of the wounds were noted. Magnetic resonance imaging of the foot was performed in all patients to diagnose osteomyelitis. All statistical analyses were done with the use of SPSS-16.</p><p><strong>Results: </strong>PCT levels were 0.13 ± 0.02 ng/mili patients with osteomyelitis (n= 45) and 0.04 ± 0.02 ng/ml in patients without osteomyelitis (n= 45). PCT, Erythrocyte sedimentation rate and C-reactive protein was found significantly higher in patients with osteomyelitis (p< 0.001). The ROC curve was calculated for PCT. The area under the ROC curve for infection identification was 1 (p< 0.001). The best cut-off value for PCT was 0.085 ng/ml. Sensitivity, specificity, and positive and negative predictive values were 100%, 97.8%,97.8% and 100%, respectively.</p><p><strong>Conclusion: </strong>In this group of patients, PCT was useful to discriminate patients with bone infection. Also, Erythrocyte sedimentation rate and C-reactive protein can be used as a marker of osteomyelitis in diabetic patients.</p>","PeriodicalId":53564,"journal":{"name":"Human Antibodies","volume":"29 2","pages":"115-121"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3233/HAB-210439","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25503009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Effect of KRAS and BRAF mutations in metastatic colorectal cancer patients: A systematic review and meta-analysis based on tumor sidedness and KRAS subtypes. KRAS和BRAF突变对转移性结直肠癌患者的影响:基于肿瘤侧边性和KRAS亚型的系统回顾和荟萃分析
Q3 Medicine Pub Date : 2021-01-01 DOI: 10.3233/HAB-210451
Khadijeh Saravani, Morteza Salarzaei, Fateme Parooie

Introduction: Metastatic or recurrent colorectal cancer (MRCRC) has a poor prognosis. The aim of the present meta-analysis was to assess the prevalence of different subtypes of KRAS mutation and BRAF mutation in metastatic CRC patients, and evaluate the relationship between the tumor sidedness and prevalence of KRAS and BRAF mutation.

Methods: We searched MEDLINE/PubMed, the Cochrane Library, and ClinicalTrials.gov from January 2010 to July 2020. The data were extracted independently according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). The statistical analysis was done using STATA and Meta-Disk 1.4 applications.

Results: Overall, 6699 colorectal cancer patients were included. KRAS and BRAF mutation was reported in 28% and 6% of patients, respectively. The overall prevalence of right primary and left primary metastatic CRC patients with mutated KRAS was 40% and 60%. However, the prevalence BRAF mutated right primary and left primary metastatic CRC patients was 37% and 63%. The overall HR was 2.38 for patients with metastatic CRC who had a mutated type of KRAS. Our study showed a mean overall survival of 35.4 month for KRAS mutant and a 10.12 month survival for BRAF mutant patients with metastatic colorectal cancer patients.

Conclusion: The prevalence of KRAS and BRAF mutations varied significantly according to the location of the tumor. BRAF mutations are more commonly found in metastatic colorectal cancers on the right side. Liver was the most common site of metastases in patients with mutant KRAS and the mortality of patients with mutant KRAS was 2.3 times higher than the patients with wild types. These results help to better describe the population of mCRC patients and can have implications for improving and organizing anti-EGFR therapies. Further research is needed to assess differences in survival through mutation status and primary tumor location.

转移性或复发性结直肠癌(MRCRC)预后较差。本meta分析的目的是评估转移性结直肠癌患者中不同亚型KRAS突变和BRAF突变的患病率,并评估肿瘤的侧边性与KRAS和BRAF突变患病率之间的关系。方法:检索2010年1月至2020年7月的MEDLINE/PubMed、Cochrane图书馆和ClinicalTrials.gov。根据系统评价和荟萃分析首选报告项目(PRISMA)独立提取数据。使用STATA和Meta-Disk 1.4应用程序进行统计分析。结果:共纳入6699例结直肠癌患者。KRAS和BRAF突变分别在28%和6%的患者中报道。KRAS突变的右原发和左原发转移性结直肠癌患者的总体患病率分别为40%和60%。然而,BRAF突变的右侧原发性和左侧原发性转移性CRC患者的患病率分别为37%和63%。KRAS突变型转移性结直肠癌患者的总HR为2.38。我们的研究显示KRAS突变体患者的平均总生存期为35.4个月,BRAF突变体患者合并转移性结直肠癌患者的平均总生存期为10.12个月。结论:KRAS和BRAF突变的发生率因肿瘤部位的不同而有显著差异。BRAF突变更常见于右侧转移性结直肠癌。肝脏是突变型KRAS患者最常见的转移部位,突变型KRAS患者的死亡率是野生型患者的2.3倍。这些结果有助于更好地描述mCRC患者群体,并可能对改善和组织抗egfr治疗具有指导意义。需要进一步的研究来评估通过突变状态和原发肿瘤位置的生存差异。
{"title":"Effect of KRAS and BRAF mutations in metastatic colorectal cancer patients: A systematic review and meta-analysis based on tumor sidedness and KRAS subtypes.","authors":"Khadijeh Saravani,&nbsp;Morteza Salarzaei,&nbsp;Fateme Parooie","doi":"10.3233/HAB-210451","DOIUrl":"https://doi.org/10.3233/HAB-210451","url":null,"abstract":"<p><strong>Introduction: </strong>Metastatic or recurrent colorectal cancer (MRCRC) has a poor prognosis. The aim of the present meta-analysis was to assess the prevalence of different subtypes of KRAS mutation and BRAF mutation in metastatic CRC patients, and evaluate the relationship between the tumor sidedness and prevalence of KRAS and BRAF mutation.</p><p><strong>Methods: </strong>We searched MEDLINE/PubMed, the Cochrane Library, and ClinicalTrials.gov from January 2010 to July 2020. The data were extracted independently according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). The statistical analysis was done using STATA and Meta-Disk 1.4 applications.</p><p><strong>Results: </strong>Overall, 6699 colorectal cancer patients were included. KRAS and BRAF mutation was reported in 28% and 6% of patients, respectively. The overall prevalence of right primary and left primary metastatic CRC patients with mutated KRAS was 40% and 60%. However, the prevalence BRAF mutated right primary and left primary metastatic CRC patients was 37% and 63%. The overall HR was 2.38 for patients with metastatic CRC who had a mutated type of KRAS. Our study showed a mean overall survival of 35.4 month for KRAS mutant and a 10.12 month survival for BRAF mutant patients with metastatic colorectal cancer patients.</p><p><strong>Conclusion: </strong>The prevalence of KRAS and BRAF mutations varied significantly according to the location of the tumor. BRAF mutations are more commonly found in metastatic colorectal cancers on the right side. Liver was the most common site of metastases in patients with mutant KRAS and the mortality of patients with mutant KRAS was 2.3 times higher than the patients with wild types. These results help to better describe the population of mCRC patients and can have implications for improving and organizing anti-EGFR therapies. Further research is needed to assess differences in survival through mutation status and primary tumor location.</p>","PeriodicalId":53564,"journal":{"name":"Human Antibodies","volume":"29 4","pages":"275-284"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3233/HAB-210451","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39264240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Relationship between health literacy and quality of life among hemodialysis patients, Tehran, Iran, 2019. 血液透析患者健康素养与生活质量的关系,德黑兰,伊朗,2019。
Q3 Medicine Pub Date : 2021-01-01 DOI: 10.3233/HAB-200423
Yisak Hagos Alemayehu, Khatereh Seylani, Farshad Sharifi, Parvaneh Asgari, Banafsheh Ghorbani, Fatemeh Bahramnezhad

Background: Chronic kidney disease and dialysis are associated with various complications.

Objective: This study aimed to determine the relationship between health literacy and quality of life among patients receiving hemodialysis in hospitals affiliated with Tehran University of Medical Sciences.

Methods: In this study, a descriptive - correlational study design with 138 sample size was used. Convenience sampling was used to select the study participants. We collected the data on May-September 2019. Data collection was done using the HELIA and KDQOL SF™.

Results: In this study, 133 respondents fully completed the questioners. The mean score of health literacy of the respondents was 49.03 (± 22.37) while the average score of quality of life of the respondents in this study was 53.01 (± 14.86).

Conclusion: Based on the findings, patients receiving haemodialysis had insufficient health literacy and a better quality of life. In order to address the health literacy needs of the patients, consideration of continuous health education and assessment in this patient subpopulation could gradually improve their health literacy and quality of life. Health care providers such as nurses could improve Health Literacy and substantially Quality of Life through interventions aimed at determining existing literacy needs in the long and short term treatment course for individual dialysis patients.

背景:慢性肾脏疾病和透析与各种并发症相关。目的:本研究旨在确定在德黑兰医科大学附属医院接受血液透析患者的健康素养与生活质量之间的关系。方法:本研究采用描述性相关研究设计,样本量为138个。采用方便抽样法选择研究对象。我们收集了2019年5月至9月的数据。使用HELIA和KDQOL SF™完成数据收集。结果:133名被调查者完整完成了问卷。调查对象健康素养平均得分为49.03(±22.37)分,生活质量平均得分为53.01(±14.86)分。结论:根据研究结果,接受血液透析的患者健康素养不足,生活质量较好。为了满足患者的健康素养需求,考虑对该患者亚群进行持续的健康教育和评估,可以逐步提高患者的健康素养和生活质量。护士等卫生保健提供者可以通过旨在确定个别透析患者在长期和短期治疗过程中现有的扫盲需求的干预措施,提高卫生扫盲水平和大幅度提高生活质量。
{"title":"Relationship between health literacy and quality of life among hemodialysis patients, Tehran, Iran, 2019.","authors":"Yisak Hagos Alemayehu,&nbsp;Khatereh Seylani,&nbsp;Farshad Sharifi,&nbsp;Parvaneh Asgari,&nbsp;Banafsheh Ghorbani,&nbsp;Fatemeh Bahramnezhad","doi":"10.3233/HAB-200423","DOIUrl":"https://doi.org/10.3233/HAB-200423","url":null,"abstract":"<p><strong>Background: </strong>Chronic kidney disease and dialysis are associated with various complications.</p><p><strong>Objective: </strong>This study aimed to determine the relationship between health literacy and quality of life among patients receiving hemodialysis in hospitals affiliated with Tehran University of Medical Sciences.</p><p><strong>Methods: </strong>In this study, a descriptive - correlational study design with 138 sample size was used. Convenience sampling was used to select the study participants. We collected the data on May-September 2019. Data collection was done using the HELIA and KDQOL SF™.</p><p><strong>Results: </strong>In this study, 133 respondents fully completed the questioners. The mean score of health literacy of the respondents was 49.03 (± 22.37) while the average score of quality of life of the respondents in this study was 53.01 (± 14.86).</p><p><strong>Conclusion: </strong>Based on the findings, patients receiving haemodialysis had insufficient health literacy and a better quality of life. In order to address the health literacy needs of the patients, consideration of continuous health education and assessment in this patient subpopulation could gradually improve their health literacy and quality of life. Health care providers such as nurses could improve Health Literacy and substantially Quality of Life through interventions aimed at determining existing literacy needs in the long and short term treatment course for individual dialysis patients.</p>","PeriodicalId":53564,"journal":{"name":"Human Antibodies","volume":"29 1","pages":"41-47"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38269911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Serological study of celiac disease in children with dental caries. 龋齿儿童乳糜泻的血清学研究。
Q3 Medicine Pub Date : 2021-01-01 DOI: 10.3233/HAB-210445
Gholamreza Kalvandi, Iraj Shahramian, Abbas Farmany, Shirin Yadegari, Fateme Parooie

Background: Celiac disease is a common gastrointestinal autoimmune disorder. Studies have shown that the prevalence of tooth decay is high in patients with celiac disease. This study was performed to evaluate the serology of celiac disease in children with dental caries.

Methods: Children aged 3 to 12 years who referred to the dental clinic with enamel caries were included in the study. Celiac disease was assessed by measuring serum IgA levels and anti-TTG (Anti TTG (IgA)) antibodies. Then, by analyzing the collected data, the prevalence of celiac disease in children with dental caries and its relationship with various variables were investigated.

Results: 120 children, 56 girls (46.7%) and 64 boys (53.3%) with dental caries were involved in this study. The positive celiac serology rate of studied population was 14 (11.6%). Based on the results of this study, a significant relationship was obtained between maternal education, sex and place of residence and celiac disease (p< 0.05). There were no significant relationships between celiac positive serology in children with dental caries, the number of decayed teeth, and breastfeeding (p> 0.05).

Conclusion: The present study showed that dental caries, might be a red flag indicating possible celiac disease and prevent its complications. On the other hand, pediatricians and dentists should be aware of the oral symptoms of celiac disease. Further studies are needed to plan screening for children with celiac disease.

背景:乳糜泻是一种常见的胃肠道自身免疫性疾病。研究表明,乳糜泻患者中蛀牙的患病率很高。本研究旨在评估患有龋齿的儿童乳糜泻的血清学。方法:以3 ~ 12岁就诊的牙釉质龋患儿为研究对象。通过测定血清IgA水平和抗TTG(抗TTG (IgA))抗体来评估乳糜泻。然后,通过分析收集到的数据,探讨乳糜泻在龋齿儿童中的患病率及其与各变量的关系。结果:本组龋病患儿120例,其中女孩56例(46.7%),男孩64例(53.3%)。研究人群乳糜泻血清学阳性率为14例(11.6%)。本研究结果显示,母亲受教育程度、性别和居住地与乳糜泻有显著相关(p< 0.05)。乳糜泻阳性血清学与龋齿数、母乳喂养无显著相关性(p> 0.05)。结论:目前的研究表明,龋齿可能是乳糜泻的一个危险信号,可以预防其并发症。另一方面,儿科医生和牙医应该了解乳糜泻的口腔症状。需要进一步的研究来计划对患有乳糜泻的儿童进行筛查。
{"title":"Serological study of celiac disease in children with dental caries.","authors":"Gholamreza Kalvandi,&nbsp;Iraj Shahramian,&nbsp;Abbas Farmany,&nbsp;Shirin Yadegari,&nbsp;Fateme Parooie","doi":"10.3233/HAB-210445","DOIUrl":"https://doi.org/10.3233/HAB-210445","url":null,"abstract":"<p><strong>Background: </strong>Celiac disease is a common gastrointestinal autoimmune disorder. Studies have shown that the prevalence of tooth decay is high in patients with celiac disease. This study was performed to evaluate the serology of celiac disease in children with dental caries.</p><p><strong>Methods: </strong>Children aged 3 to 12 years who referred to the dental clinic with enamel caries were included in the study. Celiac disease was assessed by measuring serum IgA levels and anti-TTG (Anti TTG (IgA)) antibodies. Then, by analyzing the collected data, the prevalence of celiac disease in children with dental caries and its relationship with various variables were investigated.</p><p><strong>Results: </strong>120 children, 56 girls (46.7%) and 64 boys (53.3%) with dental caries were involved in this study. The positive celiac serology rate of studied population was 14 (11.6%). Based on the results of this study, a significant relationship was obtained between maternal education, sex and place of residence and celiac disease (p< 0.05). There were no significant relationships between celiac positive serology in children with dental caries, the number of decayed teeth, and breastfeeding (p> 0.05).</p><p><strong>Conclusion: </strong>The present study showed that dental caries, might be a red flag indicating possible celiac disease and prevent its complications. On the other hand, pediatricians and dentists should be aware of the oral symptoms of celiac disease. Further studies are needed to plan screening for children with celiac disease.</p>","PeriodicalId":53564,"journal":{"name":"Human Antibodies","volume":"29 4","pages":"237-241"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3233/HAB-210445","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39065845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Zero tolerance for complacency by government of West African countries in the face of COVID-19. 面对新冠肺炎疫情,西非国家政府绝不容忍自满。
Q3 Medicine Pub Date : 2021-01-01 DOI: 10.3233/HAB-200413
O Erhabor, T Erhabor, T C Adias, G C Okara, M Retsky

A novel Coronavirus (SARS-CoV-2) causing a cluster of respiratory infections (Coronavirus Disease 2019, COVID-19) first discovered in Wuhan, China, is responsible for a new illness that has been found to affect the lungs and airways of patients with associated symptoms of fever, cough and shortness of breath. In the light of few cases recorded so far in West Africa there is tendency for complacency. The region needs to make strategic plans based on available evidence to enable them effectively deal with this rapidly evolving pandemic. At this very moment countries like China, Italy, France, Spain, Iran, UK and many others are witnessing sustained and intensive community transmission of this virus and increasing numbers of severe disease and death particularly among elderly patients with other comorbidities. The reality of the seriousness of this pandemic is alarming. Government of member states of ECOWAS need to prepare themselves by building capacity as well as implement evidenced-based steps to mitigate this rapidly evolving pandemic by testing persons presenting with symptoms (fever, cough and shortness of breath), isolating and treating those found positive, tracing and quarantining contacts, implementing social distancing as well as optimizing human and material endowment to allow healthcare workers offer safe quality clinical care for affected patients to prevent secondary infection among healthcare workers.

在中国武汉首次发现的一种新型冠状病毒(SARS-CoV-2)引起了一系列呼吸道感染(2019冠状病毒病,COVID-19),它导致了一种新的疾病,这种疾病已被发现会影响伴有发烧、咳嗽和呼吸短促等相关症状的患者的肺部和呼吸道。鉴于迄今在西非记录的病例很少,人们有自满的倾向。该区域需要根据现有证据制定战略计划,使其能够有效应对这一迅速演变的大流行病。此时此刻,中国、意大利、法国、西班牙、伊朗、英国和许多其他国家正在目睹这种病毒持续和密集的社区传播,严重疾病和死亡人数不断增加,特别是在患有其他合并症的老年患者中。这一流行病的严重性现实令人震惊。西非经共体成员国政府需要做好准备,建设能力,并采取循证措施,对出现症状(发烧、咳嗽和呼吸短促)的人进行检测,隔离和治疗阳性患者,追踪和隔离接触者,以缓解这一迅速演变的大流行病。实施社会距离并优化人力和物质资源,使卫生保健工作者能够为受影响患者提供安全优质的临床护理,以防止卫生保健工作者之间的继发感染。
{"title":"Zero tolerance for complacency by government of West African countries in the face of COVID-19.","authors":"O Erhabor,&nbsp;T Erhabor,&nbsp;T C Adias,&nbsp;G C Okara,&nbsp;M Retsky","doi":"10.3233/HAB-200413","DOIUrl":"https://doi.org/10.3233/HAB-200413","url":null,"abstract":"<p><p>A novel Coronavirus (SARS-CoV-2) causing a cluster of respiratory infections (Coronavirus Disease 2019, COVID-19) first discovered in Wuhan, China, is responsible for a new illness that has been found to affect the lungs and airways of patients with associated symptoms of fever, cough and shortness of breath. In the light of few cases recorded so far in West Africa there is tendency for complacency. The region needs to make strategic plans based on available evidence to enable them effectively deal with this rapidly evolving pandemic. At this very moment countries like China, Italy, France, Spain, Iran, UK and many others are witnessing sustained and intensive community transmission of this virus and increasing numbers of severe disease and death particularly among elderly patients with other comorbidities. The reality of the seriousness of this pandemic is alarming. Government of member states of ECOWAS need to prepare themselves by building capacity as well as implement evidenced-based steps to mitigate this rapidly evolving pandemic by testing persons presenting with symptoms (fever, cough and shortness of breath), isolating and treating those found positive, tracing and quarantining contacts, implementing social distancing as well as optimizing human and material endowment to allow healthcare workers offer safe quality clinical care for affected patients to prevent secondary infection among healthcare workers.</p>","PeriodicalId":53564,"journal":{"name":"Human Antibodies","volume":"29 1","pages":"27-40"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3233/HAB-200413","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37943132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Age-stratified pediatric reference values of lymphocytes in the Moroccan population. 摩洛哥儿童淋巴细胞的年龄分层参考值。
Q3 Medicine Pub Date : 2021-01-01 DOI: 10.3233/HAB-200432
Aicha El Allam, Sara El Fakihi, Hicham Tahoune, Karima Sahmoudi, Houria Bousserhane, Youssef Bakri, Naima El Hafidi, Fouad Seghrouchni

The number of circulating lymphocytes is altered in a number of diseases including either increase (lymphocytosis) or decrease (lymphocytopenia). Therefore, the assessment of total blood lymphocyte numbers and the relative distribution of lymphocyte subsets is a critical front-line tool in the clinical diagnosis of a number of diseases, including pediatric diseases and disorders. However, the interpretation of this data requires comparison of patient's results to reliable reference values. Blood lymphocyte subpopulation numbers are also subject to genetic polymorphisms, immunogenic and environmental factors and vary greatly between populations. While the best practice reference values should be established within local representative populations of healthy subjects, to date, Caucasian reference values are used in Morocco due to the absence of indigenous reference values. Potential differences in blood lymphocyte subpopulation reference values between Caucasian versus Moroccan populations can adversely affect the diagnosis of pediatric and childhood diseases and disorders such as primary immunodeficiency (PID) in Morocco.

Objective: The aim of this study was to establish the age-stratified normal reference values of blood lymphocyte subsets for the pediatric Moroccan population.

Methods: We measured the concentration of lymphocyte subpopulations by flow cytometry from 83 Moroccan healthy subjects stratified into 5 age groups of 0-1, 1-2, 2-6, 6-12 and > 12-18 (adult).

Results: The absolute and relative amounts of the main lymphocyte subsets of T-cells, B cells and Natural Killer (NK) cells were measured and compared to previously described reference values from Cameroonian, Turkish, American and Dutch populations. Additionally, we also observed an age-related decline in the absolute population sizes of lymphocyte subsets within our study group. Relative proportions of CD3+CD4+ helper T lymphocytes decreased with increasing age and by 12 years-adult age, both proportions of CD3+CD4+ helper T lymphocytes and CD3+CD8+ cytotoxic T lymphocytes, as well as CD3-CD19+ B lymphocytes were also decreased. Finally, we compared the median values and range of our Moroccan study group with that of published results from Cameroon, Turkey, USA and Netherlands and observed significant differences in median and mean values of absolute number and relative proportions of lymphocyte subsets especially at 0-1 years and 1-2 years age groups. Above age 12 years, the Moroccan values were lower. For NK cells, the Moroccan values are also lower.

Conclusions: The results of this study have a significant impact in improving the threshold values of the references intervals routinely used in the diagnosis of paediatric diseases such as PIDs or mother-to-child transmitted HIV within the Moroccan population.

在许多疾病中,循环淋巴细胞的数量发生改变,包括增加(淋巴细胞增多)或减少(淋巴细胞减少)。因此,评估血液淋巴细胞总数和淋巴细胞亚群的相对分布是临床诊断包括儿科疾病和障碍在内的许多疾病的关键一线工具。然而,对这些数据的解释需要将患者的结果与可靠的参考值进行比较。血液淋巴细胞亚群数量也受遗传多态性、免疫原性和环境因素的影响,在人群之间差异很大。虽然最佳做法参考值应在当地健康受试者的代表性人群中确定,但由于缺乏土著参考值,迄今为止,摩洛哥使用的是高加索参考值。高加索人与摩洛哥人之间血液淋巴细胞亚群参考值的潜在差异可能对儿科和儿童疾病的诊断产生不利影响,如摩洛哥原发性免疫缺陷(PID)。目的:本研究的目的是为摩洛哥儿童建立按年龄分层的血淋巴细胞亚群正常参考值。方法:采用流式细胞术检测83名摩洛哥健康受试者淋巴细胞亚群浓度,将其分为0-1、1-2、2-6、6-12和> 12-18(成人)5个年龄组。结果:测量了t细胞、B细胞和自然杀伤(NK)细胞的主要淋巴细胞亚群的绝对和相对数量,并与先前描述的喀麦隆、土耳其、美国和荷兰人群的参考值进行了比较。此外,我们还观察到,在我们的研究组中,淋巴细胞亚群的绝对种群大小与年龄相关。随着年龄的增长,CD3+CD4+辅助性T淋巴细胞的相对比例下降,到12 -成年时,CD3+CD4+辅助性T淋巴细胞和CD3+CD8+细胞毒性T淋巴细胞以及CD3- cd19 + B淋巴细胞的比例也下降。最后,我们将摩洛哥研究组的中位数和范围与喀麦隆、土耳其、美国和荷兰发表的结果进行了比较,发现淋巴细胞亚群绝对数量和相对比例的中位数和平均值存在显著差异,特别是在0-1岁和1-2岁年龄组。在12岁以上,摩洛哥的数值较低。对于NK细胞,摩洛哥值也较低。结论:这项研究的结果对提高参考区间的阈值具有重大影响,这些阈值通常用于诊断儿科疾病,例如在摩洛哥人口中诊断aids或母婴传播艾滋病毒。
{"title":"Age-stratified pediatric reference values of lymphocytes in the Moroccan population.","authors":"Aicha El Allam,&nbsp;Sara El Fakihi,&nbsp;Hicham Tahoune,&nbsp;Karima Sahmoudi,&nbsp;Houria Bousserhane,&nbsp;Youssef Bakri,&nbsp;Naima El Hafidi,&nbsp;Fouad Seghrouchni","doi":"10.3233/HAB-200432","DOIUrl":"https://doi.org/10.3233/HAB-200432","url":null,"abstract":"<p><p>The number of circulating lymphocytes is altered in a number of diseases including either increase (lymphocytosis) or decrease (lymphocytopenia). Therefore, the assessment of total blood lymphocyte numbers and the relative distribution of lymphocyte subsets is a critical front-line tool in the clinical diagnosis of a number of diseases, including pediatric diseases and disorders. However, the interpretation of this data requires comparison of patient's results to reliable reference values. Blood lymphocyte subpopulation numbers are also subject to genetic polymorphisms, immunogenic and environmental factors and vary greatly between populations. While the best practice reference values should be established within local representative populations of healthy subjects, to date, Caucasian reference values are used in Morocco due to the absence of indigenous reference values. Potential differences in blood lymphocyte subpopulation reference values between Caucasian versus Moroccan populations can adversely affect the diagnosis of pediatric and childhood diseases and disorders such as primary immunodeficiency (PID) in Morocco.</p><p><strong>Objective: </strong>The aim of this study was to establish the age-stratified normal reference values of blood lymphocyte subsets for the pediatric Moroccan population.</p><p><strong>Methods: </strong>We measured the concentration of lymphocyte subpopulations by flow cytometry from 83 Moroccan healthy subjects stratified into 5 age groups of 0-1, 1-2, 2-6, 6-12 and > 12-18 (adult).</p><p><strong>Results: </strong>The absolute and relative amounts of the main lymphocyte subsets of T-cells, B cells and Natural Killer (NK) cells were measured and compared to previously described reference values from Cameroonian, Turkish, American and Dutch populations. Additionally, we also observed an age-related decline in the absolute population sizes of lymphocyte subsets within our study group. Relative proportions of CD3+CD4+ helper T lymphocytes decreased with increasing age and by 12 years-adult age, both proportions of CD3+CD4+ helper T lymphocytes and CD3+CD8+ cytotoxic T lymphocytes, as well as CD3-CD19+ B lymphocytes were also decreased. Finally, we compared the median values and range of our Moroccan study group with that of published results from Cameroon, Turkey, USA and Netherlands and observed significant differences in median and mean values of absolute number and relative proportions of lymphocyte subsets especially at 0-1 years and 1-2 years age groups. Above age 12 years, the Moroccan values were lower. For NK cells, the Moroccan values are also lower.</p><p><strong>Conclusions: </strong>The results of this study have a significant impact in improving the threshold values of the references intervals routinely used in the diagnosis of paediatric diseases such as PIDs or mother-to-child transmitted HIV within the Moroccan population.</p>","PeriodicalId":53564,"journal":{"name":"Human Antibodies","volume":"29 1","pages":"85-94"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3233/HAB-200432","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38656882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Over-expression of IL-6 coding gene in the peripheral blood of migraine with aura patients. 先兆偏头痛患者外周血IL-6编码基因的过表达。
Q3 Medicine Pub Date : 2021-01-01 DOI: 10.3233/HAB-210442
Mahdi Ramezani, Alireza Komaki, Mohammad Mahdi Eftekharian, Mehrdokht Mazdeh, Soudeh Ghafouri-Fard

Migraine is a common disorder which is placed among the top ten reasons of years lived with disability. Cytokines are among the molecules that contribute in the pathophysiology of migraine. In the current study, we evaluated expression levels of IL-6 coding gene in the peripheral blood of 120 migraine patients (54 migraine without aura and 66 migraine with aura patients) and 40 healthy subjects. No significant difference was detected in expression of IL-6 between total migraine patients and healthy controls (Posterior beta = 0.253, P value = 0.199). The interaction effect between gender and group was significant (Posterior beta =-1.274, P value = 0.011), therefore, we conducted subgroup analysis within gender group. Such analysis revealed that while expression of this gene is not different between male patients and male controls (Posterior beta =-0.371, P value > 0.999), it was significantly over-expressed in female patients compared with female controls (Posterior beta = 0.86, P= 0.002). Expression of IL-6 was significantly higher in patients with aura compared with controls (Posterior beta = 0.63, adjusted P value = 0.019). However, expression of this cytokine coding gene was not different between patients without aura and healthy subjects (Posterior beta = 0.193, adjusted P value = 0.281). Therefore, IL-6 might be involved in the pathophysiology of migraine among females and migraine with aura among both sexes.

偏头痛是一种常见的疾病,是导致残疾的十大原因之一。细胞因子是参与偏头痛病理生理的分子之一。在本研究中,我们评估了120名偏头痛患者(54名无先兆偏头痛患者和66名有先兆偏头痛患者)和40名健康受试者外周血中IL-6编码基因的表达水平。总体偏头痛患者与健康对照组IL-6表达差异无统计学意义(后验β = 0.253, P值= 0.199)。性别与组间交互作用显著(后验β =-1.274, P值= 0.011),因此我们在性别组内进行亚组分析。分析结果显示,该基因在男性患者与男性对照组的表达量无差异(后验β =-0.371, P值> 0.999),而在女性患者中与女性对照组相比明显过表达(后验β = 0.86, P= 0.002)。有先兆的患者IL-6表达明显高于对照组(后验β = 0.63,校正P值= 0.019)。然而,该细胞因子编码基因在无先兆患者和健康受试者之间的表达无差异(后验β = 0.193,调整P值= 0.281)。因此,IL-6可能参与了女性偏头痛和男性先兆偏头痛的病理生理过程。
{"title":"Over-expression of IL-6 coding gene in the peripheral blood of migraine with aura patients.","authors":"Mahdi Ramezani,&nbsp;Alireza Komaki,&nbsp;Mohammad Mahdi Eftekharian,&nbsp;Mehrdokht Mazdeh,&nbsp;Soudeh Ghafouri-Fard","doi":"10.3233/HAB-210442","DOIUrl":"https://doi.org/10.3233/HAB-210442","url":null,"abstract":"<p><p>Migraine is a common disorder which is placed among the top ten reasons of years lived with disability. Cytokines are among the molecules that contribute in the pathophysiology of migraine. In the current study, we evaluated expression levels of IL-6 coding gene in the peripheral blood of 120 migraine patients (54 migraine without aura and 66 migraine with aura patients) and 40 healthy subjects. No significant difference was detected in expression of IL-6 between total migraine patients and healthy controls (Posterior beta = 0.253, P value = 0.199). The interaction effect between gender and group was significant (Posterior beta =-1.274, P value = 0.011), therefore, we conducted subgroup analysis within gender group. Such analysis revealed that while expression of this gene is not different between male patients and male controls (Posterior beta =-0.371, P value > 0.999), it was significantly over-expressed in female patients compared with female controls (Posterior beta = 0.86, P= 0.002). Expression of IL-6 was significantly higher in patients with aura compared with controls (Posterior beta = 0.63, adjusted P value = 0.019). However, expression of this cytokine coding gene was not different between patients without aura and healthy subjects (Posterior beta = 0.193, adjusted P value = 0.281). Therefore, IL-6 might be involved in the pathophysiology of migraine among females and migraine with aura among both sexes.</p>","PeriodicalId":53564,"journal":{"name":"Human Antibodies","volume":"29 3","pages":"203-207"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3233/HAB-210442","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39023248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
期刊
Human Antibodies
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1